Ensifentrine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
Phase 2 · COPD |
Verona Pharma, Inc., a subsidiary | Ensifentrine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|